US Markets for Ventricular Assist Devices 2007

Abstract

This market was valued at almost $150 million in 2007 with revenues generated by the bridge-to-transplant segment representing approximately half of the total market.

The US ventricular assist device market comprises commercially available paracorporeal and implantable devices used in bridge-to-recovery, bridge-to-transplant, and destination therapy heart failure patients.